Ergebnis der Suchanfrage nach Celle
Newsrooms
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Immunity Pharma Presents New Data Supporting the Efficacy of IPL344 in ALS
Jerusalem (ots/PRNewswire) - - Results from phase 2a trial in ALS patients were published in Muscle and Nerve. - Statistically significant 58% to 64% slower ALSFRS-R progression rate in IPL344-treated patients compared to the matched PRO-ACT records. - NfL was reduced by 27% for patients treated for at least two months. - Unadjusted median survival for participants in ...
mehrMunich Electrification joins EES EUROPE 2025
mehrFinancial Year 2024: Weleda Achieves Record Turnover and Significantly Improves Profitability
mehr- 4
PM: DHL Group erwirbt CRYOPDP von Cryoport und stärkt damit „DHL Health Logistics“ / PR: DHL Group acquires CRYOPDP from Cryoport to strengthen “DHL Health Logistics”
mehr DN Solutions, the World’s No. 3 Machine Tool Giant, Files for KOSPI Listing
Bucheon/Dormagen (ots) - Registration Filed on March 14, Targeting May IPO Market Cap up to EUR 3,6 Billion (KRW 5.7 Trillion) Expanding Automation Platform, Accelerating Digital Transformation DN Solutions, the world’s third-largest and Korea’s top machine tool company, filed a securities registration statement with the Korean Financial Services Commission on ...
mehr
- 2
GEA presents the kytero® 10, the world's smallest single use disk stack centrifuge
mehr New Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized Data
mehr- 2
Solar Energy Conference by TÜV Rheinland: new technologies, new regulation, new test methods, new failure patterns
mehr Leipzig Tourismus und Marketing GmbH
3An immersive-artistic journey through the history of life – World premiere of ‘ORIGINS - Life’s Epic Journey’ at the Kunstkraftwerk Leipzig
mehrCO.DON GmbH partners in EU-Funded Project to Advance 3D Bioprinting for Tissue Regeneration
Teltow (ots) - The EU-funded micro2MACRO (m2M) project, launched in December 2024, aims to advance tissue regeneration through an innovative bioprinting platform. m2M focuses on precisely patterning cell aggregates and microtissues into stable, customizable grafts that remodel into functional tissues after implantation. The project unites leading academic institutions, ...
mehrKinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics
Toronto (ots/PRNewswire) - Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical isotope will enable Isotopia's production of Terbium-161 (Tb-161), a medical isotope showing great promise and ...
mehr
Ancient Viral DNA Shapes Early Embryo Development
Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across the tree of life. Once dismissed as the "dark side" of the genome, researchers at Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have now revealed their crucial role in early embryo development. Unanswered Questions About the Role of Ancient Viral DNA Transposable ...
mehrBAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System
Tel Aviv, Israel (ots/PRNewswire) - The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market BAIBYS™, a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system. This milestone enables the company to ...
mehrSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
mehrBIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...
mehrNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
mehrRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
mehr
Maria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
mehrTechnische Universität München
Complex pancreatic tumor organoids as foundation for new treatment strategies
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Foundation for new cancer treatment strategies Organoids represent the complex cell landscape of pancreatic cancer - Tumors are composed of cancer cells with a variety of different characteristics. - This contributes significantly to the complexity of pancreatic cancer and makes the disease difficult to treat. - For the ...
mehrFEV and ProLogium develop high-performance vehicle battery
mehrExyte Receives Micron's Outstanding Supplier Performance Award in Supplier Diversity
Stuttgart, Germany (ots/PRNewswire) - Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, was presented with the Outstanding Supplier Performance Award in Supplier Diversity at the Micron Supplier Day 2024. The event, held in San Francisco, CA, USA, was attended by top-level management of Micron and its suppliers, including Exyte. ...
mehrInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
mehrLAMILUX AntiBac Wins “Best Food Safety Innovation of the Decade” at the Gulfood Manufacturing Awards 2024
Ein Dokumentmehr
Technische Universität München
Significant Extension of Zinc Battery Lifespan
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM Researchers Develop New Chemical Method for Improved Energy Storage Significant Extension of Zinc Battery Lifespan - Improvement to several hundred thousand charge cycles - Protective layer for zinc anode - Important result in basic research - Large-scale engineering implementation still pending The transition to renewable energy requires efficient methods for storing large ...
mehrFraunhofer-Institut für Produktionstechnologie IPT
2Deep learning for real-time quality control: Aachen-based Fraunhofer Institutes improve defect detection in weld seams
mehr- 3
GEA and Believer Meats join forces to scale up cultivated meat production
Ein Dokumentmehr RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehrPM: DHL Group beschleunigt nachhaltiges Wachstum mit der neuen Strategie 2030 / PR: DHL Group to accelerate sustainable growth with new Strategy 2030
mehr- 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr